Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(4;12)(q11-q21;p13)

Identity

Note it is likely that breakpoints are heterogeneous, with 2 distinct entities: t(4;12)(q11-12;p13) in ANLL, and t(4:12)(q13-21;p13) in ALL to be delineated
 
  t(4;12)(q11;p13) G-banding (left) - Courtesy Jacqueline Beerworth and Sarah Moore, and R-banding (right) - Courtesy Jean Philippe Rault

Clinics and Pathology

Disease ANLL and therapy related AL cases with t(4;12)(q11-12;p13); B-cell ALL cases seem to have a more distal breakpoint in 4q13 or 21
Phenotype / cell stem origin ANLL cases: M0, M1, and other subtypes; often CD7+; a stem cell may be involved; ALL cases are CD10+
Epidemiology at least 17 available cases: 13 ANLL and 4 ALL; so far, ANLL cases with a proximal breakpoint in 4 q11 or 12 are adult cases (43-81 yrs), and ALL cases are children cases (3-14 yrs); balanced sex ratio
Prognosis adult cases: response to therapy is poor and median survival might be a year

Cytogenetics

Additional anomalies none in 7/14 cases (all 7 cases are ANLL); del(6q) has recurrently been found in ALL; -7 would be recurrent if only 1 entity exists; the karyotype in ALL cases can be complex

Genes involved and Proteins

Gene Name CHIC2
Location 4q11-q12
Note CHIC2 is involved in the ANLL cases; there is no data concerning ALL cases
Protein contains a transmembrane domain; member of a family of proteins with function in exocytosis.
Gene Name ETV6
Location 12p13
Dna / Rna 9 exons; alternate splicing
Protein contains a Helix-Loop-Helix and ETS DNA binding domains; wide expression; nuclear localisation; ETS-related transcription factor

Result of the chromosomal anomaly

Hybrid gene
Description 5' CHIC2 - 3' ETV6
  
Fusion Protein
Description N term CHIC2 with the first 110 amino acids (exons 1 to 3) fused to the441 C term amino acids (exons 2 to 8) of ETV6.
  

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.
Case Report The rare t(4;12)(q11;p13) in an elderly patient with de novo AML with multilineage dysplasia co-expressing stem cell markers
Case Report t(4;12)(q11;p13) in an acute myeloid leukemia without maturation with myelodysplasia

Bibliography

Characterization of acute leukemia with t(4;12).
Harada H, Harada Y, Eguchi M, Dohy H, Kamada N
Leukemia & lymphoma. 1997 ; 25 (1-2) : 47-53.
PMID 9130613
 
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).
Cools J, Bilhou-Nabera C, Wlodarska I, Cabrol C, Talmant P, Bernard P, Hagemeijer A, Marynen P
Blood. 1999 ; 94 (5) : 1820-1824.
PMID 10477709
 

Contributor(s)

Written01-1998Jean-Loup Huret and Marina Lafage-Pochitaloff
Laboratoire de Cytogénétique Hématologique, Institut Paoli-Calmettes, Marseille, France
Updated02-2002Jean-Loup Huret

Citation

This paper should be referenced as such :
Huret JL and Lafage-Pochitaloff M . t(4;12)(q11-q21;p13). Atlas Genet Cytogenet Oncol Haematol. January 1998 .
URL : http://AtlasGeneticsOncology.org/Genes/t0412.html
Huret JL . t(4;12)(q11-q21;p13). Atlas Genet Cytogenet Oncol Haematol. February 2002 .
URL : http://AtlasGeneticsOncology.org/Genes/t0412.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Sep 5 17:09:24 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.